Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sabrina Barchuk"'
Autor:
Sofia Bruni, Florencia L Mauro, Cecilia J Proietti, Rosalia I Cordo-Russo, Martin A Rivas, Gloria Inurrigarro, Agustina Dupont, Dario Rocha, Elmer A Fernández, Ernesto Gil Deza, Daniel Lopez Della Vecchia, Sabrina Barchuk, Silvina Figurelli, David Lasso, Adrián D Friedrich, María C Santilli, María V Regge, Gabriel Lebersztein, Claudio Levit, Fabiana Anfuso, Teresa Castiglione, Patricia V Elizalde, Maria F Mercogliano, Roxana Schillaci
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background The success of HER2-positive (HER2+) breast cancer treatment with trastuzumab, an antibody that targets HER2, relies on immune response. We demonstrated that TNFα induces mucin 4 (MUC4) expression, which shields the trastuzumab epitope on
Externí odkaz:
https://doaj.org/article/260a8bffb8ab415c8e86847e61a3c8b1
Autor:
María F. Mercogliano, Gloria Inurrigarro, Mara De Martino, Leandro Venturutti, Martín A. Rivas, Rosalía Cordo-Russo, Cecilia J. Proietti, Elmer A. Fernández, Isabel Frahm, Sabrina Barchuk, Daniel H. Allemand, Silvina Figurelli, Ernesto Gil Deza, Sandra Ares, Felipe G. Gercovich, Eduardo Cortese, Matías Amasino, Pablo Guzmán, Juan C. Roa, Patricia V. Elizalde, Roxana Schillaci
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Invasive micropapillary carcinoma of the breast (IMPC) is a histological tumor variant that occurs with low frequency characterized by an inside-out formation of tumor clusters with a pseudopapillary arrangement. IMPC is an aggres
Externí odkaz:
https://doaj.org/article/58b71ec24f974724a0c1d23b8fb44294
Autor:
Nicolás Bellora, Franco Izzo, Rosalia Ines Cordo Russo, Pablo Guzmán, Juan Carlos Roa, Matías G. Pereyra, Mara De Martino, Mauro E. Cenciarini, Ezequiel Petrillo, Silvina Figurelli, Jose L. Daniotti, Daniel Lopez Della Vecchia, Osvaldo L. Podhajcer, Sabrina Barchuk, Lucía Santa María de la Parra, Patricia V. Elizalde, Violeta A. Chiauzzi, Cecilia J. Proietti, Leandro N. Guttlein, Roxana Schillaci, María F. Chervo, Agustina Dupont
Publikováno v:
Oncogene. 39:6245-6262
Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack membrane overexpression or gene amplification of ErbB-2/HER2, a receptor tyrosine kinase. Transcr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e380a9b060f637fc53453e0dda07e75
https://doi.org/10.1038/s41388-020-01430-9
https://doi.org/10.1038/s41388-020-01430-9
Autor:
Natalia, Ayala, Sabrina, Barchuk, Gloria, Inurrigarro, Constanza, Celano, Jorge Luis, Soriano-García, Patricia, Bolaños, Mónica, Mohs-Alfaro, Hector, Tapia-González, Ramón, Perez-Martinez, Suraj, Samtani, Isabel, Alvarado-Cabrero, Cynthia, Villarreal-Garza, Jaime, Tamez-Salazar, Gerardo I, Magallanes-Garza, Daniela, Vazquez, Janeth, Castro, Gabriela S, Gómez-Macías, Ana, Ferrigno, Zaida, Morante, Sheila, Vilchez, José Manuel, Cotrina, Franco, Doimi, Guianeya, Santander, Carlos, Acevedo, Virginia, Ortega, Fernando, Lavista, Lucía, Richter, Mario, Gianella, Maria, Paredes, Christian H, Flores-Balcázar, Joseph A, Pinto, Henry L, Gomez
Publikováno v:
Critical Reviews in Oncology/Hematology. 181:103890
The Breast Cancer Revealed initiative was designed and conducted to know the status of breast cancer at each point of breast cancer care, through i) prevention, ii) detection, iii) diagnosis, iv) treatment, and iv) the capacity of our health systems.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c69a6e27cf5aa7246246a6b0c71e6a1
https://doi.org/10.1016/j.critrevonc.2022.103890
https://doi.org/10.1016/j.critrevonc.2022.103890
Autor:
Patricia V Elizalde, Rosalia Cordo Russo, Santiago Madera, Sharon S Merin, María F Chervo, Esmaeil Ebrahimie, Luke Selth, Violeta A Chiauzzi, Agustina Dupont, Sabrina Barchuk, Silvina Figurelli, Daniel Lopez Della Vecchia, Pablo Guzmán, Juan C Roa, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Cecilia J Proietti, Roxana Schillaci, Theresa E Hickey, Wayne D Tilley
Publikováno v:
Journal of the Endocrine Society. 6:A878-A878
ErbB-2, a member of ErbB family of receptor tyrosine kinases, is a key oncogenic driver in breast cancer. Despite clinical efficiency of ErbB-2-targeted therapies (trastuzumab, TZ), resistance to drugs is a major issue in the clinic. While ErbB-2 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4fed870b0bb20a1ac5ef36bb608e15
https://doi.org/10.1210/jendso/bvac150.1817
https://doi.org/10.1210/jendso/bvac150.1817
Autor:
Pablo Guzmán, Juan Carlos Roa, Silvina Figurelli, Agustina Roldán Deamicis, Rosalia Ines Cordo Russo, Leandro Venturutti, Mauro E. Cenciarini, Felipe G. Gercovich, Agustina Dupont, María F. Chervo, Violeta A. Chiauzzi, Santiago Madera, Sabrina Barchuk, Daniel Lopez Della Vecchia, Cecilia Jazmín Proietti Anastasi, Patricia V. Elizalde, Matías G. Pereyra, Roxana Schillaci, Sandra L. Ares, Ernesto Gil Deza
Publikováno v:
Journal of the Endocrine Society
Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd8efa62e66cc6c4af7c9a0885b65b4
http://europepmc.org/articles/PMC7208765
http://europepmc.org/articles/PMC7208765
Autor:
Cecilia J. Proietti, Sandra L. Ares, Ernesto Gil Deza, Pablo Guzmán, Juan Carlos Roa, Agustina Dupont, Agustina Roldán Deamicis, Roxana Schillaci, Rosalia Ines Cordo Russo, Sabrina Barchuk, Franco Izzo, Felipe G. Gercovich, Matías G. Pereyra, Leandro Venturutti, Fabiana Anfuso, Patricia V. Elizalde, Eduardo Cortese, Teresa Castiglioni, Violeta A. Chiauzzi, Mauro E. Cenciarini, Santiago Madera, Gabriel Lebersztein, Silvina Figurelli, Claudio Levit, María F. Chervo, Daniel Lopez Della Vecchia
Publikováno v:
Hormonescancer. 11(5-6)
The hormone receptor-positive (estrogen and/or progesterone receptor (PR)-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that includes luminal A-like (LumA-like) and luminal B-like (LumB-like) subtypes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9fe7a71af0ab81b933a7eaec0593ad
https://pubmed.ncbi.nlm.nih.gov/32632815
https://pubmed.ncbi.nlm.nih.gov/32632815
Autor:
Elmer Andrés Fernández, Rosalía Cordo-Russo, Mara De Martino, Roxana Schillaci, Leandro Venturutti, Cecilia J. Proietti, Felipe G. Gercovich, Pablo Guzmán, Juan Carlos Roa, Isabel Frahm, Sabrina Barchuk, Matias Amasino, Patricia V. Elizalde, Gloria Inurrigarro, Silvina Figurelli, Daniel H. Allemand, Martín A. Rivas, María Florencia Mercogliano, Eduardo Cortese, Sandra L. Ares, Ernesto Gil Deza
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Cancer
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
BMC Cancer
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Invasive micropapillary carcinoma of the breast (IMPC) is a histological tumor variant that occurs with low frequency characterized by an inside-out formation of tumor clusters with a pseudopapillary arrangement. IMPC is an aggressive tumor with poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9343d239f31d92edff7b85720775cb11
http://link.springer.com/article/10.1186/s12885-017-3897-x
http://link.springer.com/article/10.1186/s12885-017-3897-x
Autor:
Pablo Rodriguez, Marcela Yoshida, Federico Leroux, Anibal Nuñez de Pierro, Sabrina Barchuk, Bruno Bustos, Giselle Pizarro, María Florencia Marchetta
Publikováno v:
Journal of Clinical Oncology. 36:e12560-e12560
e12560Background: The AJCC TNM staging system describes breast cancer (BC) stages with different prognosis for each stage. Its 8th edition (ED) added to the usual anatomic criteria, tumor biologica...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::414b892810bda7700fdeff26180094bf
https://doi.org/10.1200/jco.2018.36.15_suppl.e12560
https://doi.org/10.1200/jco.2018.36.15_suppl.e12560